Pearl AI vs Overjet: Which Dental AI Imaging Tool Is Worth It?

Two FDA-cleared tools, same price, very different use cases

Pearl AI and Overjet are the two dominant FDA-cleared players in dental AI imaging. Both function as AI overlay tools — they sit on top of your existing imaging software and analyze X-rays in real time, highlighting pathology with color-coded annotations. Neither is a full imaging suite. You still need your existing system (DEXIS, Carestream, or whatever you already run). These tools add a diagnostic interpretation layer on top.

The one structural difference that drives nearly every other distinction between them: Pearl AI focuses entirely on the provider side — the dentist, the hygienist, the patient in the chair. Overjet built a dual-sided platform that also serves insurance payers for claims review. That choice shapes their integrations, their customer targets, and how they price.

Feature comparison: what sets them apart

Pearl AI: the integration-first choice for independent practices

Pearl AI's primary advantage is integration breadth. It has direct partnerships with Dentrix, Eaglesoft, Open Dental, Carestream Dental, and Patterson Dental — covering the vast majority of practice management and imaging systems a typical dental office might run. If you're on any of these platforms, Pearl AI plugs in without a custom IT project.

Pearl also offers "Practice Intelligence" — AI-powered practice performance analytics beyond the core X-ray overlay. Pearl doesn't publicly detail which specific metrics the dashboard tracks; ask for a dedicated demo of Practice Intelligence if practice analytics matter to you as much as the diagnostic layer. Without seeing it in action, it's hard to evaluate whether it adds meaningful value beyond what your PMS already surfaces. For context on what good practice analytics looks like, see our best practice analytics software guide before you go into that demo.

Pearl AI's G2 presence is limited — the dental AI imaging category is still maturing and review counts are low across both platforms. Users who have posted reviews highlight the integration quality: "Integrates directly with PMS and imaging software." Practitioner feedback across DentalTown and Reddit's r/Dentistry is consistent: the visual annotations help explain findings to patients who might otherwise decline treatment, but the lift in case acceptance depends heavily on how the doctor uses them in the exam room.

Overjet: built for the dual sides of a dental claim

Overjet's key differentiator is its dual-sided platform. While Pearl AI focuses purely on the provider side, Overjet works with both dental providers and insurance payers. On the payer side, Overjet's AI reviews claims by analyzing submitted X-rays — the same technology that helps dentists detect pathology also helps insurers validate claims.

This dual approach gives Overjet a structural advantage with DSOs and larger groups that care about the insurance workflow alongside the clinical one. If your practice deals with frequent claims disputes or wants AI that speaks the same language as the payer reviewing your submissions, Overjet is the only dental AI tool built for both sides.

On the payer network specifically: Delta Dental is the only confirmed payer client we could verify through public sources. Overjet also claims compatibility with 300+ payers for insurance verification. Whether "compatibility with 300+ payers" means those payers actively use Overjet for clinical AI review of submitted X-rays — vs. basic eligibility verification — is a meaningful distinction. Ask Overjet to name the specific payers using their platform for claims review before treating this as a decision factor. Overjet's case studies and customer references cite strong satisfaction among DSO clients, though these are vendor-selected sources, so weight them accordingly. The more concrete service differentiator is the onboarding model: a dedicated implementation manager and structured training are included in the subscription.

Clinical accuracy: sensitivity vs. specificity tradeoff

"FDA-cleared" is a regulatory status, not a performance claim. Here's what the clinical data actually shows:

Pearl AI achieved 92% sensitivity for caries detection and 89% specificity for calculus in a multi-site study of 8,700+ radiographs. That study showed higher diagnostic accuracy than unaided dentists. Pearl received FDA 510(k) clearance (K203936) in 2021 — the first dental AI to do so.

Overjet's Caries Assist achieved 72–79.4% sensitivity with 98.1% specificity. Across its broader detection suite, Overjet reports precision and recall exceeding 91% and 93% respectively, with interreader agreement at 95.7%. Overjet holds 7 FDA 510(k) clearances — the broadest FDA-cleared indication coverage in dental AI.

The tradeoff is real: Pearl optimizes for sensitivity (catching more findings, at the cost of more false positives), while Overjet optimizes for specificity (fewer false positives, at the cost of potentially missing more). Neither approach is objectively better — it depends on whether your practice prioritizes comprehensive detection or minimal false alarms. Ask each vendor for their most recent clinical validation data and how it applies to the specific conditions your practice sees most.

Pricing and ROI: the $3,000-6,000/year question

Both tools land in the same $250-500/month range, making annual cost roughly $3,000-6,000 depending on your plan. Pearl AI is more transparent here: month-to-month subscription with a $500 non-refundable setup fee and no cancellation penalty. Overjet uses custom quotes with pricing per practice or provider (not per image).

Pearl AI's month-to-month terms are the most favorable in this category. Before signing, ask one question the published terms don't answer: what happens to your X-ray annotations and Practice Intelligence data if you cancel? Can you export your annotation history? How long does Pearl retain your data after the subscription ends? These aren't deal-breakers, but they're worth getting in writing before you commit.

The ROI math comes down to case acceptance. These tools annotate X-rays with visual findings that patients can see and understand. When a patient can look at a color-coded overlay showing exactly where decay or bone loss is, they're more likely to agree to treatment. The question is whether that lift translates to enough additional revenue to cover the subscription cost.

Break-even calculation: If your average treatment plan is $1,500-3,000 and AI-assisted case presentation converts even 1-2 additional patients per month who would otherwise have declined, the tool pays for itself. For a high-volume practice seeing 30-40+ patients per day, this is realistic. For a low-volume solo practice, the math gets tighter.

Paying $6,000/year to show patients annotated X-rays doesn't automatically translate to higher ROI. The technology works — both tools detect real pathology — but the business case depends entirely on whether your patients change their behavior when they see the overlays, and at what volume that effect adds up.

HIPAA compliance, data handling, and liability — ask before you sign

These tools analyze patient X-rays. That's PHI. For any clinical AI tool at $3,000-6,000/year, data privacy and liability exposure are decision gates, not afterthoughts — and the two vendors are meaningfully different in how openly they address them.

Data protection: Pearl AI publishes the details, Overjet doesn't

Pearl AI documents its data protection posture publicly at hellopearl.com/legal/data-protection. The key details: HIPAA compliant, GDPR compliant, ISO 13485 certified, AES-256 encryption at rest, TLS 1.2/1.3 in transit, US patient data stored in AWS, and a PHI button that masks patient names during screen sharing or demos. One notable gap: Pearl does not explicitly claim SOC 2 certification. If SOC 2 is a compliance requirement for your organization, ask directly rather than assuming.

Overjet's data handling terms are less publicly documented. Before signing, ask specifically about their BAA terms, where X-ray data is processed and stored, and whether they train their AI models on your patients' images. These are standard pre-purchase questions for any clinical AI vendor. The fact that the answers aren't easy to find publicly is a reason to ask, not a reason to assume the answers are favorable.

Liability if the AI is wrong — neither vendor answers this publicly

Neither Pearl AI nor Overjet publicly addresses what happens if the AI misses a finding or generates a false positive. That matters: if annotated X-ray findings influence clinical decisions, malpractice exposure changes. Ask each vendor what their terms of service say about the limits of AI-generated diagnostic annotations — and ask your malpractice insurer how they view AI-assisted diagnostics before deploying either tool in your clinical workflow.

Staff adoption: budget time, not just money

The break-even calculation above focuses on revenue upside. It skips transition friction. Hygienists and front desk staff need to understand what the AI overlays mean before they can use them fluently in patient conversations. Overjet includes a dedicated implementation manager and structured onboarding in the subscription — a real advantage if your team needs more than a product demo to get moving. Pearl AI's onboarding is less publicly documented; ask specifically what's included in the $500 setup fee before you pay it.

Factor ramp time into your ROI model. Neither vendor will publicly commit to a specific adoption timeline — that number depends on your team, your patient mix, and how actively your doctors use the annotations in treatment conversations. Get a realistic estimate from each vendor's implementation team before you commit.

Where each wins

Pearl AI wins on: PMS integration breadth (five major partnerships vs. Overjet's narrower set), pricing transparency (published terms, no long-term contract), HIPAA and data protection documentation, and practice analytics features beyond the core diagnostic overlay.

Overjet wins on: the dual provider + payer platform (unique in the category), DSO and enterprise positioning, white-glove onboarding and support, and the insurance claims review angle that no other dental AI tool offers.

Who should choose Pearl AI

Pearl AI is the better fit if these describe your practice:

• You're an individual practice or small group. Pearl AI's broad PMS integrations and straightforward month-to-month pricing are designed for practices that want to plug in and start using AI diagnostics without a complex sales process.
• You're on Dentrix, Eaglesoft, or Open Dental. Pearl AI has direct partnerships with all three, ensuring tight integration with the most common PMS platforms.
• You want transparent, no-commitment pricing. Month-to-month billing with no cancellation penalty lets you try it and walk away if the ROI isn't there.
• Compliance documentation matters to your organization. Pearl AI's public data protection documentation — HIPAA, GDPR, ISO 13485, AES-256 encryption, AWS data residency — is meaningfully more transparent than Overjet's. If your practice or DSO has a compliance review process before deploying clinical software, Pearl AI is easier to clear.

Who should choose Overjet

Overjet makes more sense if these ring true:

• You're a DSO or large multi-location group. Overjet's enterprise positioning, custom pricing, and structured onboarding are built for organizations buying at scale.
• You care about the insurance and payer side. If claims disputes, pre-authorization efficiency, or payer alignment matter to your practice, Overjet's dual-sided platform is the only option that covers both sides of a claim.
• You want hands-on onboarding and training. Overjet includes a dedicated implementation manager and structured onboarding — useful if your team needs more guidance adopting AI workflows than a self-serve setup provides.
• You're on Carestream Dental and need the payer-side features. Overjet has a direct Carestream partnership. Keep in mind that Pearl AI also supports Carestream — if you're on Carestream but don't need Overjet's payer-side functionality, Pearl AI is equally viable. Ask both vendors specifically how deep the Carestream integration goes (does it write findings back to the chart automatically?) before using platform alone as a tiebreaker.

Other options to consider

Pearl AI and Overjet are the two most established FDA-cleared dental AI imaging tools, but they're not the only players. If neither fits your practice, three other platforms are worth evaluating:

VideaHealth holds 3 FDA clearances and is used by 50,000+ clinicians across 50+ DSOs. VideaHealth launched the first FDA-cleared pediatric dental AI and covers 30+ conditions — broader condition coverage than either Pearl or Overjet. If your practice sees a significant pediatric population or wants the widest diagnostic net, VideaHealth is the most direct alternative.

Diagnocat focuses on CBCT and panoramic imaging rather than standard 2D radiographs. Important caveat: Diagnocat is FDA-registered for export only and is not 510(k) cleared for clinical use in the US. It's strong internationally but has limited US availability. If you're evaluating AI for 3D imaging workflows and practice outside the US, Diagnocat is worth a look. For US-based practices, it's not a viable option today.

DentalMonitoring is a different category entirely — remote orthodontic monitoring, not diagnostic imaging. If your practice includes ortho and you're looking for AI to track treatment progress between visits, DentalMonitoring solves a different problem than Pearl or Overjet.

We cover all of these alongside traditional imaging suites in our best dental imaging software guide.

The real question: is dental AI worth it?

The harder question isn't which one — it's whether either justifies $3,000-6,000/year for your practice right now. Both tools detect real pathology. Both improve patient communication through visual overlays. Both carry the same unanswered questions about liability and staff ramp time.

Practices that see the clearest ROI share two characteristics: high patient volume (enough cases that even a small percentage lift in acceptance adds up) and treatment plans where the patient's decision to proceed is influenced by visual evidence. If your practice regularly presents $1,500+ treatment plans and patients often hesitate, AI-annotated X-rays give you a concrete tool to close that gap.

Lower-volume practices or practices where case acceptance is already strong face a harder math problem. The technology is real, but the business case depends entirely on your numbers. Run the break-even calculation on your own average treatment value and current acceptance rate before committing — and factor in 2-3 months of ramp time before your team is using the overlays fluently enough to see the lift.

As AI imaging tools get bundled more tightly with PMS and imaging vendors, standalone pricing may shift — if your imaging vendor already partners with Pearl AI or Overjet, check whether a bundled deal changes the math compared to buying direct.